Navigation Links
FDA's DDMAC Provides Insight on Pharmaceutical Companies and Web 2.0 in Eye on FDA Podcast
Date:3/17/2009

Eye on FDA, a specialty blog written by Mark Senak, Senior Vice President at Fleishman-Hillard in Washington, D.C., posts an interview with the new official at FDA's DDMAC in charge of Web 2.0 policy development providing insight into FDA's point of view about the use of New and Social Media in Web 2.0 by the pharmaceutical industry.

Washington, DC (PRWEB) March 17, 2009 -- Today Eye on FDA, a specialty blog written by Mark Senak, Senior Vice President at Fleishman-Hillard in Washington, D.C., posted a podcast recorded at the FDA on March 11, 2009 that interviews Dr. Jean Ah Kang, the official at FDA's DDMAC who is in charge of policy development with respect to pharmaceutical company use of new and social media in Web 2.0 marketing and communications efforts.

The pharmaceutical industry has been slow to embrace Web 2.0 because of regulatory concerns that reaching out to patients using social and digital media might provoke action by the FDA's Division of Drug Marketing Advertising and Communications (DDMAC). To date, the FDA has relied on traditional regulatory principles in evaluating pharmaceutical company use of Web 2.0 but has provided little insight on the agency's thinking of the many evolving communications in digital and social media.

Today, Eye on FDA posted Mark Senak's podcast interview with Dr. Jean Ah Kang, Special Assistant to DDMAC head Tom Abrams, who is in charge of the development of Web 2.0 policy for the FDA. They discussed whether or not the current regulatory environment prohibits pharmaceutical involvement in Web 2.0; what kind of considerations pharmaceutical companies need to consider; FDA's thoughts on specific situations involving social and digital media use; and how companies considering digital strategies should approach the FDA for input. It may well be the most complete public statement by the FDA on the topic to date.

Makr Senak's Eye on FDA

'Eye on FDA' has a diverse 'readership', including national media, government officials, patient groups, law firms, stock analysts and pharmaceutical companies themselves.

###

Read the full story at http://www.prweb.com/releases/fda-podcast-senak/32009/prweb2239614.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related medicine news :

1. Study provides hope that some transplant patients could live free of antirejection drugs
2. Study provides hope that some transplant patients could live free of anti-rejection drugs
3. USAID Provides Additional Wildfire Assistance to Greece
4. LifeMasters Provides Tips for Maintaining a Healthy Blood Cholesterol Level
5. New knock-out gene model provides molecular clues to breast cancer
6. PreMD Provides Update on 510(k) Application for PREVU(x) POC
7. SIV infection of natural hosts provides new insights into HIV disease complexity
8. Microarray provides 3 genomic guides to breast cancer treatment decisions
9. Access Innovations Provides Support Services for Agis Network
10. Crdentias VP of Marketing, Christina Hogan, Provides Exclusive Interview on Marketing Strategy
11. Physical Therapist Provides Injury Analysis for Fantasy Football
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... ... , ... For over twenty-four years, Doctors on Liens has published a directory of ... quality medical care. When the company started in 1997, the directory was a single ... and the now ten-page directory features a vast array of medical specialists stretching ...
(Date:12/2/2016)... Portland, Maine (PRWEB) , ... December 02, 2016 , ... ... support group for caregivers of those affected by autism spectrum disorder (ASD) and other ... and Easter Seals Maine, will give parents and other caregivers the opportunity to share ...
(Date:12/2/2016)... New York, NY (PRWEB) , ... December 02, ... ... today, featuring an inspirational interview of two ostomy patients, standing as living proof ... million people suffer from digestive diseases and issues that spike around the holidays. ...
(Date:12/2/2016)... Wilmington, Delaware (PRWEB) , ... December 02, 2016 ... ... has released a new version of its SaaS LIMS, CloudLIMS Lite. CloudLIMS Lite ... from sample entry through labeling, storing, shipping and disposal. The new version is ...
(Date:12/2/2016)... PA (PRWEB) , ... December 02, 2016 , ... Rijuven ... stress and overall health, day and night. No other wearable health technology on the ... We wanted to give poeple more meaningful insights about their health than the ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... OLD LYME, Conn. , Dec. 1, 2016 /PRNewswire/ ... consulting, has announced the honor of being selected as ... that include: Simpson Healthcare Executives Website at the PLATINUM ... Directed Conversations Training Module at the GOLD Level, and ... At Simpson Healthcare Executives, we are ...
(Date:12/2/2016)... , Dec. 2, 2016 Allergan plc (NYSE: ... additional information on its previously announced Accelerated Share Repurchase (ASR) ... ... As previously announced, the Company entered into ... which the Company will repurchase $10 billion of its ordinary ...
(Date:11/30/2016)... -- Research and Markets has announced the addition of ... report to their offering. ... Detachable coil embolization is a minimally ... detachable coil embolization treatment of cerebral aneurysms is less invasive and requires ... in the wall of an artery in the brain. This area bulges ...
Breaking Medicine Technology: